InflaRx (IFRX) Short-Term Debt repayments (2019 - 2026)

InflaRx's (IFRX) quarterly Short-Term Debt repayments came in at -$87443.0 in Q1 2026, up 16.95% year-on-year from -$74769.1 in Q1 2025, and down 3.29% quarter-over-quarter from -$84656.2 in Q4 2025.

InflaRx (IFRX) Short-Term Debt repayments (2019 - 2026) Analysis & Trends

InflaRx has disclosed Short-Term Debt repayments across 8 years of filings, most recently posting -$87443.0 for Q1 2026.

  • Short-Term Debt repayments for Q1 2026 came in at -$87443.0, up 16.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$384391.5 (up 11.06% YoY), and the FY2025 annual result was -$416242.2, changed 0.36% from the prior year.
  • Short-Term Debt repayments came in at -$87443.0 for Q1 2026 at InflaRx, down from -$84656.2 in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of -$84656.2 in Q4 2025 to a low of -$115600.7 in Q2 2024.
  • The 5-year median for Short-Term Debt repayments is -$100619.4 (2023), against an average of -$99910.2.
  • Across the five-year window, Short-Term Debt repayments retreated 16.6% in 2024 and climbed 19.14% in 2025, its largest moves.
  • InflaRx's Short-Term Debt repayments stood at -$93187.4 in 2022, then dropped by 9.57% to -$102108.8 in 2023, then dropped by 2.53% to -$104689.2 in 2024, then climbed by 19.14% to -$84656.2 in 2025, then declined by 3.29% to -$87443.0 in 2026.
  • The last three Short-Term Debt repayments figures came in at -$87443.0 (Q1 2026), -$84656.2 (Q4 2025), and -$99314.7 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 102,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -482,347.21
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -87,442.99

Historic Data

Download Data
DateValue
Mar 31, 2026 -87,442.99
Mar 31, 2026 -87,442.99
Dec 31, 2025 -84,656.23
Dec 31, 2025 -84,656.23
Sep 30, 2025 -99,314.74
Sep 30, 2025 -99,314.74
Jun 30, 2025 -112,977.50
Jun 30, 2025 -112,977.50
Mar 31, 2025 -105,290.48
Mar 31, 2025 -105,290.48
Dec 31, 2024 -104,689.22
Dec 31, 2024 -104,689.22
Sep 30, 2024 -106,628.33
Sep 30, 2024 -106,628.33
Jun 30, 2024 -115,600.65
Jun 30, 2024 -115,600.65
Mar 31, 2024 -93,107.72
Mar 31, 2024 -93,107.72
Dec 31, 2023 -102,108.85
Dec 31, 2023 -102,108.85